GBLX - GB Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
3,504
3,455
2,510
0
0
Cost of Revenue
4,844
3,246
783
-
-
Gross Profit
-1,340
208
1,728
-
-
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
11,648
15,803
19,552
8,933
6,959
Total Operating Expenses
11,648
15,803
19,552
8,933
6,959
Operating Income or Loss
-12,988
-15,594
-17,825
-8,933
-6,959
Interest Expense
1,682
5,191
5,176
901
105
Total Other Income/Expenses Net
-349
-3,369
-158
-249
-15
Income Before Tax
-15,019
-24,154
-23,159
-10,083
-7,079
Income Tax Expense
526
526
-
-
-
Income from Continuing Operations
-15,546
-24,680
-23,159
-10,083
-7,079
Net Income
-13,836
-23,653
-22,974
-9,910
-6,771
Net Income available to common shareholders
-16,697
-26,515
-22,974
-9,910
-6,771
Reported EPS
Basic
-
-0.13
-0.17
-0.13
-0.15
Diluted
-
-0.13
-0.17
-0.13
-0.15
Weighted average shares outstanding
Basic
-
209,538
132,934
79,003
44,912
Diluted
-
209,538
132,934
79,003
44,912
EBITDA
-
-18,340
-17,178
-8,766
-6,797